CF Plus Chemicals at European Antibody Congress in Basel
The CEO of the company CF Plus Chemicals Dr. Václav Matoušek is presenting a poster on the company´s technology "Togni reagents as efficient tools for stable and site-selective functionalisation of biogenous thiols: towards the next generation of highly-specific ADC Therapeutics" at the European Antibody Congress held in Basel on 29-31st October.
Come and discover more about our bioconjugation technology.